BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.050
-0.020 (-1.87%)
At close: Sep 25, 2026, 4:00 PM EDT
1.070
+0.020 (1.90%)
After-hours: Sep 25, 2026, 7:22 PM EDT
BioCardia Market Cap
BioCardia has a market cap or net worth of $15.9 million as of September 25, 2026. Its market cap has increased by 1.24% in one year.
Market Cap
15.90M
Enterprise Value
12.07M
1-Year Change
1.24%
Ranking
Category
Stock Price
$1.05
ChartMarket Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $15.90M, a decrease of -45.33%. That is a compound annual growth rate of -5.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 15.90M | 19.82% |
| Dec 31, 2025 | 13.27M | 32.74% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kiora Pharmaceuticals | 16.74M |
| Pasithea Therapeutics | 16.68M |
| Palatin Technologies | 16.60M |
| Allarity Therapeutics | 16.39M |
| Actuate Therapeutics | 16.33M |
| Citius Pharmaceuticals | 15.88M |
| Chemomab Therapeutics | 15.65M |
| Lantern Pharma | 15.60M |